Ashleen Sappal
Regulatory Affairs Practice – Europe
OVERVIEW
FOCUS AREAS
Over 5 years of experience within the scientific discipline conducting clinical research.
Pharmacology models
Clinical terminology
Technical writing
Project-management
Pro-active mind-set and innovative thinker, to complement 5+ years of strong clinical expertise, from clinical trials to drug development. Ashleen acquires a strategic work ethic and high standard of adaptability, allowing her to tackle any regulatory issue faced. Having extensive experience in the clinical field, she has built meticulous regulatory knowledge to accompany her skills, allowing her to provide each regulatory solution efficiently and effectively.
Through completing her Bachelors and Masters in a scientific discipline, Ashleen has gained extensive clinical expertise and practical experience, for example when conducting clinical research on a range of human conditions. In doing so, she gained a strong familiarity with scientific concepts and clinical terminology, which she was able to apply to each of her work experience. For example, when completing her internship within clinical trials, she gained a broad range of knowledge, from regulatory standards to patient safety, which she can apply here at Eliquent to solve each regulatory issue faced.
-
Education
MSc Molecular Biosciences (Medical Biosciences) – University of Bath
BSc Biomedical Science – University of Kent
-
– Managed and co-ordinated clinical trials, providing clinical expertise, ensuring patient safety and supporting the analysis of clinical data to generate a scientific publication
– Conducted extensive clinical research on a range of human diseases, including cardiovascular and oncology, through strategizing therapeutic solutions and drug-drug interactions
– Presented and discussed a diversity of medical issues to senior academic audiences, through defining clinical concepts and providing future therapeutic guidance
Ready for Regulatory Clarity?
Stay informed as the regulatory landscape evolves.
Subscribe to our blog to receive the latest updates on policy changes, FDA developments, and their impact on the life sciences industry.